EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Elevated Lipoprotein(a) Predicts Recurrent Myocardial Infarction in Diabetic Patients Following Acute Coronary Syndromes

Ermilo Echeverria-Ortegon iD, Mario César Torres-Chávez iD, Alfredo Pérez-Tagle Tejeda iD, Paulina Caballero-Osorno iD, Juan Pastor-Cervantes, Hugo Laviada-Molina iD

Clinical Cardiology · 2026-11 · 49 (11)

DOI: 10.1002/clc.70480 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Cardiology, online erschienen am 31.10.2026. Verfasst von Ermilo Echeverria-Ortegon und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Health Sciences, Universidad Marista de Mérida, Merida, Yucatan, Mexico. Hauptthemen laut MEDLINE: Lipoprotein(a), Acute Coronary Syndrome, Myocardial Infarction, Diabetes Mellitus, Type 2. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with type 2 diabetes mellitus (T2DM) who experience acute coronary syndromes (ACS) remain at high risk for recurrent ischemic events despite secondary prevention. Lipoprotein(a) [Lp(a)] contributes to residual cardiovascular risk, but its prognostic impact on recurrent myocardial infarction (MI) and repeat revascularization in diabetic patients after ACS or percutaneous coronary intervention (PCI) remains unclear. Hypothesis We hypothesized that elevated Lp(a) is associated with increased risk of recurrent MI and repeat coronary revascularization in patients with diabetes after ACS or PCI.

Methods

We conducted a PRISMA‐guided systematic review and meta‐analysis. PubMed, EBSCOhost, and Cochrane Library were searched for studies evaluating Lp(a) and recurrent cardiovascular outcomes in patients with diabetes after ACS or PCI. Observational studies reporting hazard ratios (HRs) with 95% confidence intervals (CIs) were included. Pooled HRs were calculated using random‐effects models.

Results

Seven studies comprising 7887 patients with diabetes and prior ACS or PCI were included. Elevated Lp(a) was associated with increased risk of recurrent MI (pooled HR 2.17, 95% CI 1.02–4.62; I 2 = 75%) but not repeat coronary revascularization (pooled HR 1.68, 95% CI 0.79–3.57; I 2 = 78%).

Conclusions

Elevated Lp(a) was associated with increased risk of recurrent MI in patients with diabetes after ACS or PCI. Findings should be interpreted considering the observational study designs, substantial heterogeneity, and limited evidence for repeat revascularization. These findings support Lp(a) as a contributor to residual cardiovascular risk and its potential role in post‐ACS risk stratification. Trial Registration: This study was prospectively registered in the International Prospective Register of Systematic Reviews (PROSPERO; registration number CRD420261296821).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)Acute Coronary SyndromeMyocardial InfarctionDiabetes Mellitus, Type 2Percutaneous Coronary InterventionHumansRecurrenceRisk FactorsBiomarkersPrognosisRisk Assessment

Substanzen

Lipoprotein(a)BiomarkersLPA protein, human

Autor:innen und Institutionen

  • School of Health Sciences, Universidad Marista de Mérida, Merida, Yucatan, Mexico.
  • Facultad de Medicina Mexicali, Universidad Autonoma de Baja California, Mexicali, Baja California, Mexico.
  • Memorial Healthcare System, Hollywood, Florida, USA.
  • Department of Cardiovascular Disease, Memorial Healthcare System, Hollywood, Florida, USA.

ORCID-Profile: Ermilo Echeverria-Ortegon, Mario César Torres-Chávez, Alfredo Pérez-Tagle Tejeda, Paulina Caballero-Osorno, Hugo Laviada-Molina

Zitieren

APA

Echeverria-Ortegon, E., Torres-Chávez, M. C., Tejeda, A. P., Caballero-Osorno, P., Pastor-Cervantes, J., & Laviada-Molina, H. (2026). Elevated Lipoprotein(a) Predicts Recurrent Myocardial Infarction in Diabetic Patients Following Acute Coronary Syndromes. Clinical Cardiology, 49(11). https://doi.org/10.1002/clc.70480

Vancouver

Echeverria-Ortegon E, Torres-Chávez MC, Tejeda AP, Caballero-Osorno P, Pastor-Cervantes J, Laviada-Molina H. Elevated Lipoprotein(a) Predicts Recurrent Myocardial Infarction in Diabetic Patients Following Acute Coronary Syndromes. Clinical Cardiology. 2026;49(11). doi:10.1002/clc.70480

BibTeX
@article{EcheverriaOrtegon2026,
  author = {Echeverria-Ortegon, Ermilo and Torres-Chávez, Mario César and Tejeda, Alfredo Pérez-Tagle and Caballero-Osorno, Paulina and Pastor-Cervantes, Juan and Laviada-Molina, Hugo},
  title = {Elevated Lipoprotein(a) Predicts Recurrent Myocardial Infarction in Diabetic Patients Following Acute Coronary Syndromes},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {11},
  doi = {10.1002/clc.70480}
}
Kostenlos starten →